S'abonner

Toll-like receptor 7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice - 29/04/13

Doi : 10.1016/j.jaci.2013.02.041 
Gerard E. Kaiko, PhD, BBiomedSc (Hons) a, b, c, Zhixuan Loh, BSc (Hons) d, Kirsten Spann, PhD, BSc (Hons) e, f, Jason P. Lynch, BSc (Hons) d, Amit Lalwani, BSc (Hons) d, Zhenglong Zheng, BSc (Hons) d, Sophia Davidson, BSc (Hons) a, b, Satoshi Uematsu, MD, PhD g, Shizuo Akira, MD, PhD g, John Hayball, PhD h, Kerrilyn R. Diener, PhD h, i, Katherine J. Baines, PhD, BBiomedSci (Hons) a, j, Jodie L. Simpson, PhD, BSc (Hons) a, j, Paul S. Foster, PhD, BSc (Hons) a, b, c, Simon Phipps, PhD, BSc (Hons) d, f,
a Centre for Asthma and Respiratory Diseases, University of Newcastle, Newcastle, Australia 
b Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia 
c Cooperative Research Centre (CRC) for Asthma and Airways, Sydney, Australia 
d School of Biomedical Sciences, University of Queensland, Queensland, Australia 
e Sir Albert Sakzewski Virus Research Centre, University of Queensland, Queensland, Australia 
f Australian Infectious Diseases Research Centre, University of Queensland, Queensland, Australia 
g Laboratory of Host Defence, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan 
h Experimental Therapeutics Laboratory, Sansom Institute, University of South Australia, Adelaide, Australia 
i Robinson Institute, University of Adelaide, Adelaide, Australia 
j Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, John Hunter Hospital, Newcastle, Australia 

Corresponding author: Simon Phipps, PhD, BSc (Hons), School of Biomedical Sciences, University of Queensland, S. Lucia, Queensland 4072, Australia.

Abstract

Background

Respiratory tract viruses are a major environmental risk factor for both the inception and exacerbations of asthma. Genetic defects in Toll-like receptor (TLR) 7–mediated signaling, impaired type I interferon responses, or both have been reported in asthmatic patients, although their contribution to the onset and exacerbation of asthma remains poorly understood.

Objective

We sought to determine whether Pneumovirus infection in the absence of TLR7 predisposes to bronchiolitis and the inception of asthma.

Methods

Wild-type and TLR7-deficient (TLR7−/−) mice were inoculated with the rodent-specific pathogen pneumonia virus of mice at 1 (primary), 7 (secondary), and 13 (tertiary) weeks of age, and pathologic features of bronchiolitis or asthma were assessed. In some experiments infected mice were exposed to low-dose cockroach antigen.

Results

TLR7 deficiency increased viral load in the airway epithelium, which became sloughed and necrotic, and promoted an IFN-⍺/βlow, IL-12p70low, IL-1βhigh, IL-25high, and IL-33high cytokine microenvironment that was associated with the recruitment of type 2 innate lymphoid cells/nuocytes and increased TH2-type cytokine production. Viral challenge of TLR7−/− mice induced all of the cardinal pathophysiologic features of asthma, including tissue eosinophilia, mast cell hyperplasia, IgE production, airway smooth muscle alterations, and airways hyperreactivity in a memory CD4+ T cell–dependent manner. Importantly, infections with pneumonia virus of mice promoted allergic sensitization to inhaled cockroach antigen in the absence but not the presence of TLR7.

Conclusion

TLR7 gene defects and Pneumovirus infection interact to establish an aberrant adaptive response that might underlie virus-induced asthma exacerbations in later life.

Le texte complet de cet article est disponible en PDF.

Key words : Toll-like receptor 7, Pneumovirus, infection, type 2 innate lymphoid cell, nuocyte, asthma, IL-13, exacerbation, respiratory syncytial virus, bronchiolitis

Abbreviations used : AEC, APC, BAL, cDC, DLN, dpi, ILC, LRT, pDC, PE, PFU, PRR, PVM, RSV, TLR7, TSLP


Plan


 Supported by a National Health and Medical Research Council of Australia project grant (to S.P. and J.L.S.).
 Disclosure of potential conflict of interest: G. E. Kaiko has received travel support from the Keystone Symposia. J. L. Simpson and S. Phipps have received grants from the National Health and Medical Research Council. The rest of the authors declare that they have no relevant conflicts of interest.


© 2013  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 131 - N° 5

P. 1331 - mai 2013 Retour au numéro
Article précédent Article précédent
  • Peripheral lung function in patients with stable and unstable asthma
  • Bruce R. Thompson, Jo A. Douglass, Matthew J. Ellis, Vanessa J. Kelly, Robyn E. O’Hehir, Gregory G. King, Sylvia Verbanck
| Article suivant Article suivant
  • Multiple breath nitrogen washout profiles in asthmatic patients: What do they mean clinically?
  • David A. Kaminsky

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.